(Q74590600)
Statements
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group (English)
J M FitzGerald
K R Chapman
G Della Cioppa
D Stubbing
M S Fairbarn
M D Till